Global Startups Insights
Lets your startup
Florida, Funding News, USA Startup Funding News

H Clinical Receives Majority Investment from Emerald Square Ventures

September 16, 2026
By
Loren Baker
H Clinical Receives Majority Investment from Emerald Square Ventures

H Clinical, a clinical research services company focused on Latin America, has announced a majority investment from Emerald Square Ventures (ESV).

Mitchell Parrish will continue as CEO. H Clinical has also appointed Ben Joers as CFO and Eddie Hannush as Chief Commercial Officer.

The investment will support the expansion of H Clinical’s clinical research services, including site staffing, patient recruitment, in-home and hybrid trial support, procurement, and logistics.

“What we have spent six years building is difficult to build and impossible to shortcut — people in the communities where trials run, their relationships with sites, and the infrastructure behind them,” said Mitchell Parrish, CEO of H Clinical. “This investment puts more of it in front of clients.”

“We work with sponsors, CROs, and sites in whatever combination a study needs,” said Eddie Hannush, Chief Commercial Officer. “When staffing, recruitment, home visits and logistics run off one local platform, the study moves faster and the patient has a better experience.”

H Clinical operates through in-country teams across 22 countries in Latin America, supporting pharmaceutical companies, clinical research organizations, and research sites.

Recommended Stories for You